Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayse Mavi

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Clinical Nuclear Medicine|February 22, 2005
Reflux esophagitis secondary to chemotherapy detected by serial FDG-PETGonca Gul Bural, Rakesh Kumar, Ayse Mavi, et al.
Molecular Imaging and Biology|November 15, 2007
Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology?Sandip Basu, Ayse Mavi, Tevfik Cermik, et al.
Radiologic Clinics of North America|October 19, 2004
PET: a revolution in medical imagingAbass Alavi, Paras Lakhani, Ayse Mavi, et al.
Radiologic Clinics of North America|February 8, 2005
Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancerAyse Mavi, Paras Lakhani, Hongming Zhuang, et al.
Radiologic Clinics of North America|October 19, 2004
Normal variants in [18F]-fluorodeoxyglucose PET imagingGhassan El-Haddad, Abass Alavi, Ayse Mavi, et al.
Clinical Nuclear Medicine|March 15, 2005
FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literatureRakesh Kumar, Yan Xiu, Ayse Mavi, et al.
Clinical Nuclear Medicine|April 7, 2007
FDG PET in detecting primary and recurrent malignant salivary gland tumorsTevfik Fikret Cermik, Ayse Mavi, Gunsel Acikgoz, et al.
Hellenic Journal of Nuclear Medicine|March 31, 2009
Usefulness of non attenuation corrected 18F-FDG-PET images for optimal assessment of disease activity in patients with lymphomaMohamed Houseni, Wichana Chamroonrat, Sandip Basu, et al.
Clinical Nuclear Medicine|December 24, 2005
Malignant lesions can mimic gastric uptake on FDG PETWichana Chamroonrat, Hongming Zhuang, Mohamed Houseni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 27, 2007
Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurementMuammer Urhan, Simin Dadparvar, Ayse Mavi, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Clinical Nuclear Medicine|February 22, 2005
Reflux esophagitis secondary to chemotherapy detected by serial FDG-PETGonca Gul Bural, Rakesh Kumar, Ayse Mavi, et al.
Molecular Imaging and Biology|November 15, 2007
Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology?Sandip Basu, Ayse Mavi, Tevfik Cermik, et al.
Radiologic Clinics of North America|October 19, 2004
PET: a revolution in medical imagingAbass Alavi, Paras Lakhani, Ayse Mavi, et al.
Radiologic Clinics of North America|February 8, 2005
Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancerAyse Mavi, Paras Lakhani, Hongming Zhuang, et al.
Radiologic Clinics of North America|October 19, 2004
Normal variants in [18F]-fluorodeoxyglucose PET imagingGhassan El-Haddad, Abass Alavi, Ayse Mavi, et al.
Clinical Nuclear Medicine|March 15, 2005
FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literatureRakesh Kumar, Yan Xiu, Ayse Mavi, et al.
Clinical Nuclear Medicine|April 7, 2007
FDG PET in detecting primary and recurrent malignant salivary gland tumorsTevfik Fikret Cermik, Ayse Mavi, Gunsel Acikgoz, et al.
Hellenic Journal of Nuclear Medicine|March 31, 2009
Usefulness of non attenuation corrected 18F-FDG-PET images for optimal assessment of disease activity in patients with lymphomaMohamed Houseni, Wichana Chamroonrat, Sandip Basu, et al.
Clinical Nuclear Medicine|December 24, 2005
Malignant lesions can mimic gastric uptake on FDG PETWichana Chamroonrat, Hongming Zhuang, Mohamed Houseni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 27, 2007
Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurementMuammer Urhan, Simin Dadparvar, Ayse Mavi, et al.
Pageof 3